Does rosmarinic acid underestimate as an experimental cardiovascular drug?

Does rosmarinic acid underestimate as an experimental cardiovascular drug?

PURPOSE: The rationale of the present review is to analize the activity of Rosmarinus officinalis in the the cardiovascular system METHODS: A MEDLINE database search (from January 1970 to December 2011) using only rosmarinic acid as searched term. RESULTS: The references search revealed 509 references about rosmarinic acid in 40 years (the first reference is from 1970). There is a powerful prevalence of antioxidant and cancer studies. Other diseases are few cited, as inflammation, brain (Alzheimer and Parkinson disease) and, memory; allergy; diabetes; atherosclerosis, and; hypertension. It is necessary to consider the complete absence of studies on coronary artery disease, myocardial ischemia, heart failure or ischemia/reperfusion injury. CONCLUSION: Rosmarinic acid is underestimated as an experimental cardiovascular drug and deserves more attention.

Saved in:
Bibliographic Details
Main Authors: Ferreira,Luciana Garros, Celotto,Andrea Carla, Capellini,Verena Kise, Albuquerque,Agnes Afrodite Sumarelli, Nadai,Tales Rubens de, Carvalho,Marco Tulio Menezes de, Evora,Paulo Roberto Barbosa
Format: Digital revista
Language:English
Published: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502013001300016
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0102-86502013001300016
record_format ojs
spelling oai:scielo:S0102-865020130013000162013-02-01Does rosmarinic acid underestimate as an experimental cardiovascular drug?Ferreira,Luciana GarrosCelotto,Andrea CarlaCapellini,Verena KiseAlbuquerque,Agnes Afrodite SumarelliNadai,Tales Rubens deCarvalho,Marco Tulio Menezes deEvora,Paulo Roberto Barbosa Rosmarinus officinalis Polyphenols Cardiovascular diseases PURPOSE: The rationale of the present review is to analize the activity of Rosmarinus officinalis in the the cardiovascular system METHODS: A MEDLINE database search (from January 1970 to December 2011) using only rosmarinic acid as searched term. RESULTS: The references search revealed 509 references about rosmarinic acid in 40 years (the first reference is from 1970). There is a powerful prevalence of antioxidant and cancer studies. Other diseases are few cited, as inflammation, brain (Alzheimer and Parkinson disease) and, memory; allergy; diabetes; atherosclerosis, and; hypertension. It is necessary to consider the complete absence of studies on coronary artery disease, myocardial ischemia, heart failure or ischemia/reperfusion injury. CONCLUSION: Rosmarinic acid is underestimated as an experimental cardiovascular drug and deserves more attention.info:eu-repo/semantics/openAccessSociedade Brasileira para o Desenvolvimento da Pesquisa em CirurgiaActa Cirúrgica Brasileira v.28 suppl.1 20132013-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502013001300016en10.1590/S0102-86502013001300016
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ferreira,Luciana Garros
Celotto,Andrea Carla
Capellini,Verena Kise
Albuquerque,Agnes Afrodite Sumarelli
Nadai,Tales Rubens de
Carvalho,Marco Tulio Menezes de
Evora,Paulo Roberto Barbosa
spellingShingle Ferreira,Luciana Garros
Celotto,Andrea Carla
Capellini,Verena Kise
Albuquerque,Agnes Afrodite Sumarelli
Nadai,Tales Rubens de
Carvalho,Marco Tulio Menezes de
Evora,Paulo Roberto Barbosa
Does rosmarinic acid underestimate as an experimental cardiovascular drug?
author_facet Ferreira,Luciana Garros
Celotto,Andrea Carla
Capellini,Verena Kise
Albuquerque,Agnes Afrodite Sumarelli
Nadai,Tales Rubens de
Carvalho,Marco Tulio Menezes de
Evora,Paulo Roberto Barbosa
author_sort Ferreira,Luciana Garros
title Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title_short Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title_full Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title_fullStr Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title_full_unstemmed Does rosmarinic acid underestimate as an experimental cardiovascular drug?
title_sort does rosmarinic acid underestimate as an experimental cardiovascular drug?
description PURPOSE: The rationale of the present review is to analize the activity of Rosmarinus officinalis in the the cardiovascular system METHODS: A MEDLINE database search (from January 1970 to December 2011) using only rosmarinic acid as searched term. RESULTS: The references search revealed 509 references about rosmarinic acid in 40 years (the first reference is from 1970). There is a powerful prevalence of antioxidant and cancer studies. Other diseases are few cited, as inflammation, brain (Alzheimer and Parkinson disease) and, memory; allergy; diabetes; atherosclerosis, and; hypertension. It is necessary to consider the complete absence of studies on coronary artery disease, myocardial ischemia, heart failure or ischemia/reperfusion injury. CONCLUSION: Rosmarinic acid is underestimated as an experimental cardiovascular drug and deserves more attention.
publisher Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502013001300016
work_keys_str_mv AT ferreiralucianagarros doesrosmarinicacidunderestimateasanexperimentalcardiovasculardrug
AT celottoandreacarla doesrosmarinicacidunderestimateasanexperimentalcardiovasculardrug
AT capelliniverenakise doesrosmarinicacidunderestimateasanexperimentalcardiovasculardrug
AT albuquerqueagnesafroditesumarelli doesrosmarinicacidunderestimateasanexperimentalcardiovasculardrug
AT nadaitalesrubensde doesrosmarinicacidunderestimateasanexperimentalcardiovasculardrug
AT carvalhomarcotuliomenezesde doesrosmarinicacidunderestimateasanexperimentalcardiovasculardrug
AT evorapaulorobertobarbosa doesrosmarinicacidunderestimateasanexperimentalcardiovasculardrug
_version_ 1756400941495484416

Similar Items